Welcome to the Legal Playground: The TransMedics Investigation Come Play with Us! Hey there fellow investors and law enthusiasts! Have you heard the latest news about TransMedics Group, Inc. (NASDAQ: TMDX)? Well, buckle up because the law firm of Robbins Geller Rudman & Dowd LLP is diving deep into potential violations of U.S. federal securities…
NewAmsterdam Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) NAARDEN, The Netherlands and MIAMI, Nov. 01, 2024 (GLOBE NEWSWIRE) NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for…
KWESST Micro Systems Inc. Closes Public Offering Ottawa, Ontario–(Newsfile Corp. – November 1, 2024) KWESST Micro Systems Inc. (NASDAQ: KWE) (NASDAQ: KWESW) (TSXV: KWE), a leading technology company, has successfully closed its public offering of common shares. The offering consisted of 3,889,000 common shares at a price of US$0.90 per share, resulting in gross proceeds of…
Solana’s Q3 Funding Skyrockets to $173M: PayPal and Visa Show Growing Institutional Interest in Cryptocurrency Solana’s Impressive Growth in Q3 Solana’s (CRYPTO: SOL) ecosystem experienced significant financial and institutional growth in the third quarter of the year, securing a total of $173 million in new funding across 29 different projects. This impressive achievement comes despite…
Welcome to the Future of Investing with uMINT UBS Asset Management Debuts Tokenized Money Market Fund on Ethereum In an exciting development for the world of finance, UBS Asset Management has recently launched the UBS USD Money Market Investment Fund Token, or uMINT, on the Ethereum blockchain. This innovative new offering is specifically targeted at…
The Impact of Recent Events on the U.S. Economy and Election Day Introduction As Election Day approaches, the U.S. economy is facing challenges due to recent events that have skewed the jobs report. Hurricanes and a strike at Boeing have contributed to this confusion, creating uncertainty for voters as they prepare to make their decision…
Welcome to the Nasdaq Compliance Party! No More Rule-Breaking for Cellectar Biosciences, Inc. Well, well, well, look who’s back in the good graces of Nasdaq! Cellectar Biosciences, Inc. (NASDAQ: CLRB) has officially received a letter from Nasdaq, Inc. on this fine November 1st, 2024, stating that they are now in compliance with Nasdaq Listing Rule…
Spyre Therapeutics Announces Equity Inducement Awards Company Overview Spyre Therapeutics, Inc. is a clinical-stage biotechnology company focused on utilizing antibody engineering and precision medicine to enhance the treatment of Inflammatory Bowel Disease (IBD). The company aims to improve efficacy and convenience for patients suffering from this chronic condition. Equity Inducement Awards On November 1, 2024,…
